101 Therapeutics
Alec Goldberg has a diverse work experience. In 2013, they worked as a Summer Analyst at Battery Ventures. In 2014, they joined Echo Therapeutics as a Manager of Business Development, where they stayed until 2017. In 2017, Alec became a CPM at Qubit., and they worked there until 2018. Most recently, in 2019, they co-founded 101 Therapeutics and took on the role of Co-Founder & CEO.
Alec Goldberg graduated from Columbia College, Columbia University with a Bachelor of Arts (BA) degree in Philosophy. Alec attended the university from 2010 to 2014.
This person is not in any teams
This person is not in any offices
101 Therapeutics
101 Therapeutics is a Phase II pharmaceutical company on a mission to cure infectious diseases by targeting the pathology not the the pathogen. After a successful Phase I safety trial, 101 Therapeutics is conducting a Phase II efficacy trials for its targeted COVID-19 therapy.